Nattala Pharmaceuticles (Opc) Private Limited - Company Profile

It is a healthcare enterprise based in Ludhiana, Punjab, India, established in 2018.
2018 Ludhiana, Punjab, India Active
Last Updated:
Access Report
About Nattala Pharmaceuticles (Opc) Private Limited

Nattala Pharmaceuticles (Opc) Private Limited, Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U74999PB2018OPC047708. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Priyanka Sharma (Director). Its latest balance sheet filed on 31 March 2024. It is based at Street No. 1, Punjabi Bagh, Near Garewal Chakki, Tibba Road,, Ludhiana, Punjab, 141008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999PB2018OPC047708

  • Registration Number

    047708

  • Incorporation Date

    06 April 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -53.95%
  • Profit Growth **** 314.86%
  • Ebitda **** -198.28%
  • Net Worth 303.63%
  • Total Assets **** 23.23%
Company report

Nattala Pharmaceuticles (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nattala Pharmaceuticles (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nattala Pharmaceuticles (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Priyanka Sharma Director 06 Apr 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nattala Pharmaceuticles (Opc).

Nattala Pharmaceuticles (Opc) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.95% decrease. The company also saw a substantial improvement in profitability, with a 314.86% increase in profit. The company's net worth Soared by an impressive increase of 303.63%.

Nattala Pharmaceuticles (Opc) revenue growth over time
Nattala Pharmaceuticles (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -53.95%
*******
*******
*******
*******
Revenue from Operations
*******
 -53.95%
*******
*******
*******
*******
Total Assets
*******
 23.23%
*******
*******
*******
*******
Profit or Loss
*******
 314.86%
*******
*******
*******
*******
Net Worth
*******
 303.63%
*******
*******
*******
*******
EBITDA
*******
 -198.28%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nattala Pharmaceuticles (Opc)?

Unlock access to Nattala Pharmaceuticles (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nattala Pharmaceuticles (Opc)?

Unlock and access historical data on people associated with Nattala Pharmaceuticles (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nattala Pharmaceuticles (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nattala Pharmaceuticles (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nattala Pharmaceuticles (Opc)
Recent Activity within the Organization
  • Balance Sheet

    Progress on Nattala Pharmaceuticles (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.

  • Director Appointment

    Priyanka Sharma was appointed as a Director was appointed as a Director on 06 Apr 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Nattala Pharmaceuticles (Opc) Private Limited was registered on 06 Apr 2018 with Roc Chandigarh & aged 7 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nattala Pharmaceuticles (Opc) Private Limited?

The CIN of Nattala Pharmaceuticles (Opc) Private Limited is U74999PB2018OPC047708.

Where is Nattala Pharmaceuticles (Opc) Private Limited headquartered?

Nattala Pharmaceuticles (Opc) Private Limited is headquartered at Street No. 1, Punjabi Bagh, Near Garewal Chakki, Tibba Road,, Ludhiana, Punjab, 141008.

When was Nattala Pharmaceuticles (Opc) Private Limited incorporated?

Nattala Pharmaceuticles (Opc) Private Limited was incorporated on 06 April 2018.

Who are the current directors of Nattala Pharmaceuticles (Opc) Private Limited?

The current directors of Nattala Pharmaceuticles (Opc) Private Limited are

What is the primary industry of Nattala Pharmaceuticles (Opc) Private Limited?

The primary industry of Nattala Pharmaceuticles (Opc) Private Limited is Manufacturing.

Is Nattala Pharmaceuticles (Opc) Private Limited a listed company?

Nattala Pharmaceuticles (Opc) Private Limited is unlisted.

What is the capital structure of Nattala Pharmaceuticles (Opc) Private Limited?

The authorized capital of Nattala Pharmaceuticles (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available